ALLR
Price:
$3.35
Market Cap:
$4.73M
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 cli...[Read more]
Industry
Biotechnology
IPO Date
2021-12-21
Stock Exchange
NASDAQ
Ticker
ALLR
According to Allarity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -13175622.00. This represents a change of -119.67% compared to the average of 66.97M of the last 4 quarters.
The mean historical Enterprise Value of Allarity Therapeutics, Inc. over the last ten years is 4.62B. The current -13175622.00 Enterprise Value has changed -128.54% with respect to the historical average. Over the past ten years (40 quarters), ALLR's Enterprise Value was at its highest in in the June 2021 quarter at 79.01B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.
Average
4.62B
Median
1.03B
Minimum
34.05M
Maximum
19.97B
Discovering the peaks and valleys of Allarity Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 90.38%
Maximum Annual Enterprise Value = 19.97B
Minimum Annual Increase = -95.63%
Minimum Annual Enterprise Value = 34.05M
Year | Enterprise Value | Change |
---|---|---|
2023 | 34.05M | -60.26% |
2022 | 85.68M | -95.63% |
2021 | 1.96B | 90.38% |
2020 | 1.03B | -94.84% |
The current Enterprise Value of Allarity Therapeutics, Inc. (ALLR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
693.47M
5-year avg
4.62B
10-year avg
4.62B
Allarity Therapeutics, Inc.’s Enterprise Value is less than Immix Biopharma, Inc. (27.90M), less than CNS Pharmaceuticals, Inc. (3.40M), less than eFFECTOR Therapeutics, Inc. (3.86M), less than Navidea Biopharmaceuticals, Inc. (-2504975.00), less than Sonnet BioTherapeutics Holdings, Inc. (1.10M), less than Virios Therapeutics, Inc. (2.47M), less than Zura Bio Limited (41.78M), less than ZyVersa Therapeutics, Inc. (2.43M), less than Quoin Pharmaceuticals, Ltd. (-338152.00), less than Kiromic BioPharma, Inc. (11.97M), less than Virax Biolabs Group Limited (9.05M), less than Biodexa Pharmaceuticals Plc (-5428645.20), less than Apexigen, Inc. (0), less than Phio Pharmaceuticals Corp. (205.32K), less than null (-1904616.00),
Company | Enterprise Value | Market cap |
---|---|---|
27.90M | $50.78M | |
3.40M | $4.76M | |
3.86M | $223.46K | |
-2504975.00 | $100.08K | |
1.10M | $4.50M | |
2.47M | $5.49M | |
41.78M | $230.22M | |
2.43M | $2.54M | |
-338152.00 | $2.51M | |
11.97M | $2.78M | |
9.05M | $12.42M | |
-5428645.20 | $103.47K | |
0 | $9.57M | |
205.32K | $2.79M | |
-1904616.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allarity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Allarity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Allarity Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Allarity Therapeutics, Inc. (ALLR)?
What is the 3-year average Enterprise Value for Allarity Therapeutics, Inc. (ALLR)?
What is the 5-year average Enterprise Value for Allarity Therapeutics, Inc. (ALLR)?
How does the current Enterprise Value for Allarity Therapeutics, Inc. (ALLR) compare to its historical average?